Published in Obesity and Diabetes Week, February 14th, 2005
Mellon has received compensation in the form of stock from HEE Corporation.
"We have examined numerous products in the diabetes prevention arena and have decided to support HEE Corporation (OTCBB:HCCF) to grow HEE Corporation as the pre-eminent producer of type two diabetes prevention here in the United States and further abroad as well." Quoted Mario Pino CEO of Mellon Research.
"Type two diabetes plagues many families in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.